[Potentiation of focal ultrasound treatment of prostate adenocarcinoma by concomitant chemotherapy with estramustine phosphate and paclitaxel].
暂无分享,去创建一个
[1] L. Pisters,et al. Cryotherapy for prostate cancer , 2003, Expert review of anticancer therapy.
[2] K. Wallner,et al. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. , 2003, The Journal of urology.
[3] A. Rademaker,et al. Phase I Trial of Oral Estramustine and 3-hr Infusional Paclitaxel for the Treatment of Hormone Refractory Prostate Cancer , 2002, Cancer investigation.
[4] P. Huber,et al. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound , 2000, Gene Therapy.
[5] J M Dubernard,et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. , 2000, Journal of endourology.
[6] M. Bolla,et al. Données actuelles de l'association radiothérapie-hormonothérapie dans les cancers de la prostate localisés et localement évolués , 1998 .
[7] J M Dubernard,et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. , 1996, European urology.
[8] T. Ponchon,et al. In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat. , 1974, British Journal of Cancer.
[9] J. Chapelon,et al. Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. , 1992, European urology.
[10] F. Fry,et al. Tumor irradiation with intense ultrasound. , 1978, Ultrasound in medicine & biology.
[11] G. Murphy,et al. Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma. , 1977, Urology.